Skip Nav Destination
Issues
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Advances in Brief
Molecular Biology, Pathobiology, and Genetics
Mismatch Repair Gene PMS2: Disease-Causing Germline Mutations Are Frequent in Patients Whose Tumors Stain Negative for PMS2 Protein, but Paralogous Genes Obscure Mutation Detection and Interpretation
Hidewaki Nakagawa; Janet C. Lockman; Wendy L. Frankel; Heather Hampel; Kelle Steenblock; Lawrence J. Burgart; Stephen N. Thibodeau; Albert de la Chapelle
Embryonic Stem Cell-Like Features of Testicular Carcinoma in Situ Revealed by Genome-Wide Gene Expression Profiling
Kristian Almstrup; Christina E. Hoei-Hansen; Ute Wirkner; Jonathon Blake; Christian Schwager; Wilhelm Ansorge; John E. Nielsen; Niels E. Skakkebæk; Ewa Rajpert-De Meyts; Henrik Leffers
Cell and Tumor Biology
Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade
Hongzhen Li; Tommi J. Ahonen; Kalle Alanen; Jianwu Xie; Matthew J. LeBaron; Thomas G. Pretlow; Erica L. Ealley; Ying Zhang; Martti Nurmi; Baljit Singh; Paula M. Martikainen; Marja T. Nevalainen
Induction of Centrosome Amplification and Chromosome Instability in Human Bladder Cancer Cells by p53 Mutation and Cyclin E Overexpression
Kenji Kawamura; Hideki Izumi; Zhiyong Ma; Ryosuke Ikeda; Manabu Moriyama; Tatsuro Tanaka; Takayuki Nojima; Linda S. Levin; Kohzaburo Fujikawa-Yamamoto; Koji Suzuki; Kenji Fukasawa
Expression of Angiogenic Factors Vascular Endothelial Growth Factor and Interleukin-8/CXCL8 Is Highly Responsive to Ambient Glutamine Availability: Role of Nuclear Factor-κB and Activating Protein-1
Ekaterina V. Bobrovnikova-Marjon; Philip L. Marjon; Olena Barbash; David L. Vander Jagt; Steve F. Abcouwer
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth in Vitro and in Vivo
Barbara A. Spruce; Lorna A. Campbell; Niall McTavish; Michelle A. Cooper; M. Virginia L. Appleyard; Mary O’Neill; Jacqueline Howie; Jayne Samson; Stephen Watt; Karen Murray; Doris McLean; Nick R. Leslie; Stephen T. Safrany; Michelle J. Ferguson; John A. Peters; Alan R. Prescott; Gary Box; Angela Hayes; Bernard Nutley; Florence Raynaud; C. Peter Downes; Jeremy J. Lambert; Alastair M. Thompson; Suzanne Eccles
A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction
Ling Geng; Jiahuai Tan; Eric Himmelfarb; Aaron Schueneman; Ken Niermann; Allie Fu; Kyle Cuneo; Edward A. Kesicki; Jennifer Treiberg; Joel S. Hayflick; Dennis E. Hallahan
AEE788: A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity
Peter Traxler; Peter R. Allegrini; Ralf Brandt; Josef Brueggen; Robert Cozens; Doriano Fabbro; Konstantina Grosios; Heidi A. Lane; Paul McSheehy; Jürgen Mestan; Thomas Meyer; Careen Tang; Markus Wartmann; Jeanette Wood; Giorgio Caravatti
Immunology
A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates
Richard Lo-Man; Sophie Vichier-Guerre; Ronald Perraut; Edith Dériaud; Valérie Huteau; Lbachir BenMohamed; Ousmane M. Diop; Philip O. Livingston; Sylvie Bay; Claude Leclerc
Dendritic Cells Pulsed with an Anti-Idiotype Antibody Mimicking Carcinoembryonic Antigen (CEA) Can Reverse Immunological Tolerance to CEA and Induce Antitumor Immunity in CEA Transgenic Mice
Asim Saha; Sunil K. Chatterjee; Kenneth A. Foon; F. James Primus; Sunil Sreedharan; Kartik Mohanty; Malaya Bhattacharya-Chatterjee
Epidemiology and Prevention
Corrections
Advertisement